Drug Testing Locations - Highland Acres, DE

Drug Testing in Highland Acres, DE

Highland Acres, Delaware Statistics

In 2020, Highland Acres, located in Kent County, reported a 15% increase in opioid-related overdoses.

Highland Acres saw a 10% year-over-year rise in drug-related arrests in 2019, reflecting broader county trends.

Kent County officials noted that Highland Acres had one of the highest rates of substance abuse treatment admissions in 2021.

Fentanyl was involved in over 60% of drug-related deaths in Highland Acres, DE, in the year 2021.

Highland Acres in Kent County experienced a 25% increase in drug-related emergency room visits in 2020.

Alcohol remained the most commonly used substance among youth in Highland Acres as surveyed in 2021.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Highland Acres, DE & Drug Testing Policies

Employers in Highland Acres, DE, are increasingly implementing strict drug testing policies to maintain safe and productive workplaces. Many businesses align with federal guidelines provided by the U.S. Department of Labor, conducting pre-employment and random drug tests.

Drug testing policies in Highland Acres often include mandatory testing post-accident or upon reasonable suspicion of drug use. These measures aim to deter substance abuse among employees and ensure compliance with both local and state regulations, such as those detailed by the Delaware Department of Labor.

Government Efforts with Drug Problems in Highland Acres, DE

In recent years, the government has increased efforts to combat drug abuse in Highland Acres, DE, situated in Kent County. Programs focusing on prevention have been rolled out by local agencies such as the Delaware Division of Public Health. These initiatives include educational campaigns and support networks.

The state government, supported by federal grants, has provided funding for community outreach and enhanced treatment facilities in Highland Acres. Collaboration with organizations like SAMHSA has facilitated broader access to prevention and treatment services, aiming to decrease the region's drug-related incidents.

Local Drug Busts & News in Highland Acres, DE

Highland Acres, DE has been a focal point for several significant drug busts in recent years, highlighting the area's drug-related challenges. In 2022, local law enforcement, supported by the Kent County Drug Task Force, seized large quantities of illicit substances during operations.

These drug interdictions have led to the arrest of key figures in local drug trafficking rings, substantially disrupting the distribution networks in Kent County. Community engagement events focusing on drug abuse awareness have been pivotal in educating residents about the potential hazards associated with substance abuse.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Highland Acres, DE. Trusted by employers nationwide for accurate results and exceptional service.

Delaware DOT/Non DOT Physicals

Delaware Vision Tests

Delaware Audiograms

Delaware Respirator Fit Tests

Delaware Lift Tests

Delaware Background Checks

Clinical Testing Services

TB Testing in DE

Diabetes Testing in DE

Infectious Disease Testing in DE

Sickle Cell Anemia Testing in DE

Women/Men's Health Testing in DE

Resources & Citations

Overdose Free PA

ATTC Network - Northeast & Caribbean

White Horse Recovery

Gaudenzia

Attorney General DE: Drug Abuse

Calm Center

Project Purple

Nar-Anon Family Groups

Drug Testing Near Highland Acres, DE

Bowers Beach, DE

Viola, DE

Little Creek, DE

Central Kent, DE

Woodside East, DE

Woodside, DE

Dover, DE

Wyoming, DE

Rising Sun-Lebanon, DE

Lebanon, DE

Rodney Village, DE

Kent Acres, DE

Frequently Asked Questions

Customer Reviews